Nuzenio

Stock Titan Gyre

Stock Titan Gyre entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Fri, 07 Aug 2026 21:01:46 GMTGyre Therapeutics (NASDAQ: GYRE) swings to 32,849 H1 2026 net loss - Stock Titan

Fri, 07 Aug 2026 11:00:00 GMTAbout $300M Cullgen deal adds cancer candidates to Gyre's pipeline - Stock Titan

Wed, 05 Aug 2026 08:37:45 GMTGyre Therapeutics, Inc. (GYRE) grants director options on 40,000 shares - Stock Titan

Wed, 05 Aug 2026 08:32:36 GMTGyre Therapeutics (GYRE) director discloses no stock ownership - Stock Titan

Wed, 05 Aug 2026 08:17:28 GMTGyre Therapeutics (GYRE) awards director 40,000 stock options vesting to 2029 - Stock Titan

Wed, 05 Aug 2026 08:16:44 GMTWeston Claire files initial ownership report at Gyre Therapeutics (GYRE) - Stock Titan

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Gyre.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.